FTC to Enforce the Robinson-Patman Act in Prescription Drug Industry
FTC explained that the Act is one of several authorities at its disposal to combat the use of rebate and fee agreements offered by prescription drug manufacturers used to steer patients to higher-cost drugs.
Source: natlawreview.com